Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Orthocell Ltd logo — Orthocell (ASX:OCC) is a regenerative medicine company empow...

Orthocell Ltd

Orthocell (ASX:OCC) is a regenerative medicine company empowering the body to heal | Tag or follow us at $OCC

Founded 2006 Australia Australia 42 employees Post Ipo Equity Total: $1.80M Biotechnology, Health and Wellness

General Information

Company Name Orthocell Ltd
Founded Year 2006
Location Australia Australia +1
Employees 42
Industries Biotechnology, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when Orthocell Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Orthocell Ltd

Orthocell is a regenerative medicine company with a focus on biotechnology based in Australia. Established in 2008, the company is dedicated to developing breakthrough products that harness the power of the human body to heal, aiming to restore mobility, function, and performance. Orthocell's product portfolio comprises two complementary platform products - a collagen medical device and autologous cell therapies. The CelGro™ platform of collagen medical devices is specifically designed to augment the surgical repair of bone, nerve, tendon, and cartilage. On the other hand, the company's cell therapies encompass autologous tendon therapy and autologous chondrocyte implantation (OrthoACI™), aiming to facilitate the regeneration of damaged tendon and cartilage tissue. Though specific details regarding the company's last investment remain undisclosed, it is clear that Orthocell presents an intriguing proposition within the regenerative medicine space. As a venture capital entity, monitoring the company's advancements and potential opportunities for collaboration could prove to be valuable in staying abreast of innovative developments within the biotechnology sphere. Keep an eye on Orthocell (ASX:OCC) for further insights and investment prospects.

Taxonomy: Regenerative Medicine, Soft Tissue Repair, Stem Cell Therapy, Orthopaedics, Sports Science, Exercise Physiology, Bio-therapeutic Company, Collagen Medical Devices, Autologous Cell Therapies, Tendon Therapy, Chondrocyte Implantation, Healthcare Innovation, Tissue Regeneration, Medical Technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 11 Dec 2018

Latest News

View All
WA Medtech Startups Showcased On Global Stage At LSI Asia 2025 — Startupnews
WA Medtech Startups Showcased On Global Stage At LSI Asia 2025
Startupnews Jun 08, 2025

Orthocell Ltd Alternatives & Competitors

Orthocell Ltd vs
PUR Biologics
PUR Biologics United States

The Authority in Ortho and Spinal Biologics

2 employees
Biotechnology, Health Care
Compare Orthocell Ltd vs PUR Biologics
Orthocell Ltd vs
Celling Biosciences
Celling Biosciences United States

Market leader focused on the science, R&D, & education of autologous cellular therapy and its synerg...

47 employees
Biotechnology
Compare Orthocell Ltd vs Celling Biosciences
Orthocell Ltd vs
China Regenerative Medicine International
China Regenerative Medicine International Hong Kong S.a.r.

Pioneering the future of regenerative medicine with advanced gene and stem cell products.

16 employees
Biotechnology, Manufacturing
Compare Orthocell Ltd vs China Regenerative Medicine International

FAQ About Orthocell Ltd

Orthocell (ASX:OCC) is a regenerative medicine company empowering the body to heal | Tag or follow us at $OCC
Orthocell Ltd was founded in 2006.
Orthocell Ltd is headquartered in Australia.
Orthocell Ltd operates in the following industries: Biotechnology, Health and Wellness.
Orthocell Ltd has approximately 42 employees.
Orthocell Ltd has completed 1 funding round, raising a total of $1.80M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Orthocell Ltd include PUR Biologics, Celling Biosciences, China Regenerative Medicine International, Cellf BIO, Inc., NKGen Biotech, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orthocell Ltd and PUR Biologics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Orthocell Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy